Claudia Asperti

490 total citations
15 papers, 366 citations indexed

About

Claudia Asperti is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Claudia Asperti has authored 15 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology and Allergy. Recurrent topics in Claudia Asperti's work include Cell Adhesion Molecules Research (7 papers), CAR-T cell therapy research (5 papers) and Virus-based gene therapy research (4 papers). Claudia Asperti is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), CAR-T cell therapy research (5 papers) and Virus-based gene therapy research (4 papers). Claudia Asperti collaborates with scholars based in Italy, Spain and United Kingdom. Claudia Asperti's co-authors include Ivan de Curtis, Veronica Astro, Simona Paris, Antonio Totaro, Catia Traversari, Barbara Valentinis, Simona Porcellini, Claudio Doglioni, Maria Giulia Cangi and Claudio Bordignon and has published in prestigious journals such as Angewandte Chemie International Edition, The EMBO Journal and Blood.

In The Last Decade

Claudia Asperti

15 papers receiving 365 citations

Peers

Countries citing papers authored by Claudia Asperti

Since Specialization

Citations

This map shows the geographic impact of Claudia Asperti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Asperti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Asperti more than expected).

Fields of papers citing papers by Claudia Asperti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Asperti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Asperti. The network helps show where Claudia Asperti may publish in the future.

Co-authorship network of co-authors of Claudia Asperti

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Asperti. A scholar is included among the top collaborators of Claudia Asperti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Asperti. Claudia Asperti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo 2023 ·Molecular Therapy — Methods & Clinical Development ·Claudia Asperti, Daniele Canarutto, Simona Porcellini, Francesca Sanvito, Francesca Cecere, Valentina Vavassori, Samuele Ferrari, (unknown), Luisa Albano, Aurélien Jacob, Lucia Sergi Sergi, Elisa Montaldo, Francesca Ferrua, Luis Ignacio González‐Granado, Vassilios Lougaris, Raffaele Badolato, Andrea Finocchi, Anna Villa, Marina Radrizzani, Luigi Naldini	3
2	Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4 ⁺ T‐cells for the treatment of Hyper IgM1 2023 ·The EMBO Journal ·Daniele Canarutto, Claudia Asperti, Valentina Vavassori, Simona Porcellini, (unknown), Marianna Paulis, Samuele Ferrari, Angelica Varesi, (unknown), Aurélien Jacob, Lucia Sergi Sergi, Ilaria Visigalli, Francesca Ferrua, Luis Ignacio González‐Granado, Vassilios Lougaris, Andrea Finocchi, Anna Villa, Marina Radrizzani, Luigi Naldini	5
3	Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells 2023 ·Blood ·Valentina Vavassori, Samuele Ferrari, Stefano Beretta, Claudia Asperti, Luisa Albano, Andrea Annoni, (unknown), Angelica Varesi, Monica Soldi, Alessandro Cuomo, Tiziana Bonaldi, Marina Radrizzani, Ivan Merelli, Luigi Naldini	40
4	Characterization and Functional Analysis of CD44v6.CAR T Cells Endowed with a New Low-Affinity Nerve Growth Factor Receptor-Based Spacer 2021 ·Human Gene Therapy ·Anna Stornaiuolo, Barbara Valentinis, (unknown), Cinzia Scavullo, Claudia Asperti, Dan Zhou, Yeny Martinez de la Torre, (unknown), Monica Casucci, Simona Porcellini, Catia Traversari	18
5	CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice 2020 ·Frontiers in Immunology ·Simona Porcellini, Claudia Asperti, (unknown), (unknown), Veronica Valtolina, Anna Stornaiuolo, Barbara Valentinis, Claudio Bordignon, Catia Traversari	53
6	Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling 2019 ·International Journal of Molecular Sciences ·Barbara Valentinis, Simona Porcellini, Claudia Asperti, Manuela Cota, Dan Zhou, Paola Di Matteo, G. Garau, (unknown), Nilla Avanzi, Gian Paolo Rizzardi, Massimo Degano, Giovanna Musco, Catia Traversari	21
7	Codon Optimization Leads to Functional Impairment of RD114-TR Envelope Glycoprotein 2017 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Monika Pema, Anna Stornaiuolo, Claudia Piovan, Cinzia Scavullo, Erica Giuliani, (unknown), (unknown), Claudia Asperti, Claudio Bordignon, Gian‐Paolo Rizzardi, Chiara Bovolenta	11
8	The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms 2015 ·OncoImmunology ·Simona Porcellini, Claudia Asperti, Barbara Valentinis, (unknown), (unknown), Claudio Bordignon, Gian‐Paolo Rizzardi, Catia Traversari	12
9	Molecular Dynamics Reveal that isoDGR‐Containing Cyclopeptides Are True αvβ3 Antagonists Unable To Promote Integrin Allostery and Activation 2012 ·Angewandte Chemie International Edition ·Michela Ghitti, Andrea Spitaleri, Barbara Valentinis, Silvia Mari, Claudia Asperti, Catia Traversari, Gian Paolo Rizzardi, Giovanna Musco	38
10	Molecular Dynamics Reveal that isoDGR‐Containing Cyclopeptides Are True αvβ3 Antagonists Unable To Promote Integrin Allostery and Activation 2012 ·Angewandte Chemie ·Michela Ghitti, Andrea Spitaleri, Barbara Valentinis, Silvia Mari, Claudia Asperti, Catia Traversari, Gian Paolo Rizzardi, Giovanna Musco	8
11	Biochemical and Functional Characterization of the Interaction between Liprin-α1 and GIT1: Implications for the Regulation of Cell Motility 2011 ·PLoS ONE ·Claudia Asperti, Veronica Astro, (unknown), Simona Paris, Angela Bachi, Ivan de Curtis	10
12	Liprin-α1 affects the distribution of low-affinity β1 integrins and stabilizes their permanence at the cell surface 2010 ·Experimental Cell Research ·Claudia Asperti, (unknown), Ivan de Curtis	23
13	Liprin-α1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradation 2010 ·Oncogene ·Veronica Astro, Claudia Asperti, Maria Giulia Cangi, Claudio Doglioni, Ivan de Curtis	46
14	Liprin-α1 promotes cell spreading on the extracellular matrix by affecting the distribution of activated integrins 2009 ·Journal of Cell Science ·Claudia Asperti, Veronica Astro, Antonio Totaro, Simona Paris, Ivan de Curtis	52
15	Identification of an Intramolecular Interaction Important for the Regulation of GIT1 Functions 2007 ·Molecular Biology of the Cell ·Antonio Totaro, Simona Paris, Claudia Asperti, Ivan de Curtis	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact